 | Up a level |
Perreault, Leigh, Davies, Melanie, Frias, Juan P, Laursen, Peter Norkjaer, Lingvay, Ildiko, Machineni, Sriram, Varbo, Anette, Wilding, John PH 
ORCID: 0000-0003-2839-8404, Wallenstein, Signe Olrik Rytter and le Roux, Carel W
(2022)
Changes in Glucose Metabolism and Glycemic Status With Once-Weekly Subcutaneous Semaglutide 2.4 mg Among Participants With Prediabetes in the STEP Program.
DIABETES CARE, 45 (10).
pp. 2396-2405.
Harman, Nicola ORCID: 0000-0001-6958-6466, Wilding, John ORCID: 0000-0003-2839-8404, Curry, Dave, Harris, James, Logue, Jennifer, Pemberton, R John, Perreault, Leigh, Thompson, Gareth, Tunis, Sean, Williamson, Paula R ORCID: 0000-0001-9802-6636 et al (show 1 more authors)
(2019)
Selecting Core Outcomes for Randomised Effectiveness Trials in Type 2 Diabetes (SCORE-IT) - a Patient and Healthcare Professional Consensus on a Core Outcome Set for Type 2 Diabetes.
BMJ Open Diabetes Research and Care, 7 (1).
e000700-.
Harman, Nicola L ORCID: 0000-0001-6958-6466, Wilding, John ORCID: 0000-0003-2839-8404, Curry, Dave, Harris, James, Logue, Jennifer, Pemberton, R John, Perreault, Leigh, Thompson, Gareth, Tunis, Sean and Williamson, Paula R ORCID: 0000-0001-9802-6636
(2018)
Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 Diabetes (SCORE-IT): study protocol for the development of a core outcome set.
TRIALS, 19 (1).
427-.